TY - JOUR T1 - Measure what matters: counts of hospitalized patients are a better metric for health system capacity planning for a reopening JF - medRxiv DO - 10.1101/2020.04.19.20072017 SP - 2020.04.19.20072017 AU - Sehj Kashyap AU - Saurabh Gombar AU - Steve Yadlowsky AU - Alison Callahan AU - Jason Fries AU - Benjamin A Pinsky AU - Nigam H Shah Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/04/26/2020.04.19.20072017.abstract N2 - Responding to the COVID-19 pandemic requires accurate forecasting of health system capacity requirements using readily available inputs. We examined whether testing and hospitalization data could help quantify the anticipated burden on the health system given shelter-in-place (SIP) order.We find a marked slowdown in the hospitalization rate within ten days of SIP even as cases continued to rise. We also find a shift towards younger patients in the age distribution of those testing positive for COVID-19 over the four weeks of SIP. The impact of this shift is a divergence between increasing positive case confirmations and slowing new hospitalizations, both of which affects the demand on health systems.Without using local hospitalization rates and the age distribution of positive patients, current models are likely to overestimate the resource burden of COVID-19. It is imperative that health systems start using these data to quantify effects of SIP and aid reopening planning.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by NLM grant R01LM011369-07, Stanford Health CEO’s Innovation Fund and the Debra and Mark Leslie endowment for AI in Healthcare.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesPatient-level healthcare data are not publicly available. Code to reproduce technical aspects of the analysis is available from the corresponding author by request. ER -